trial · primary record
PF-08165784
Advanced Breast Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 268 |
| Primary completion | 2032-03-21 |
| Primary endpoint | Part 1 (Dose Escalation): Number of participants with Dose-Limiting Toxicities (DLT) |
| Registry ID | NCT07897721 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:01.061Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897721
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.